NOVANTA INC
Company Stats
- Market Cap
- $5.4B
- as of Sep 30, 2026
- Enterprise Value
- $5.2B
- Shares Outstanding
- 37.8M
- Free Float
- 88.0%
Income Statement
- Revenue
- $980.6M
- Operating Income
- $94.0M
- Net Income
- $53.8M
- EBITDA
- $155.9M
- Revenue Growth, 3Y
- 4.4%
- FCF Margin, 3Y Avg
- 10.4%
- FCF Margin, Worst Year
- 4.9%
Cash Flow
- Free Cash Flow
- $48.4M
- FCF Yield
- 0.9%
- Owner FCF Yield
- 0.4%
Balance Sheet
- Cash & Equivalents
- $380.9M
- Total Debt
- $250.8M
- Net Cash
- $130.0M
- EV / EBITDA
- 33.65x
Returns & Capital
- Share Repurchases
- $39.3M
- SBC, 3Y Avg
- $26.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $980.6M | $48.4M | 4.9% |
| FY2024 | $949.2M | $141.3M | 14.9% |
| FY2023 | $881.7M | $100.1M | 11.4% |
| FY2022 | $860.9M | $71.1M | 8.3% |
| FY2021 | $706.8M | $74.6M | 10.6% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 10, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Novanta to Buy Riverpoint Medical in $1.2 Billion All-Cash Deal